The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drug Discovery Enzymes-Global Market Insights and Sales Trends 2024
Synopsis
The global Drug Discovery Enzymes market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drug Discovery Enzymes in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Company, Research Institutes and Others,, are propelling Drug Discovery Enzymes market. Active Kinases, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ubiquitin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Discovery Enzymes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Discovery Enzymes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Discovery Enzymes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Discovery Enzymes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Discovery Enzymes covered in this report include Sigma-Aldrich Co. LLC., Kaneka Corporation, Actelion Pharmaceuticals Ltd, Genesis Biotechnology Group, Suven Life Sciences Limited, Enzo Life Sciences and Merck KGaA, etc.
The global Drug Discovery Enzymes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sigma-Aldrich Co. LLC.
Kaneka Corporation
Actelion Pharmaceuticals Ltd
Genesis Biotechnology Group
Suven Life Sciences Limited
Enzo Life Sciences
Merck KGaA
Global Drug Discovery Enzymes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Discovery Enzymes market, Segment by Type:
Active Kinases
Ubiquitin
Methyltransferases
Deacetylases (hdacs)
Phosphodiesterases (pdes)
Others
Global Drug Discovery Enzymes market, by Application
Pharmaceutical and Biotechnology Company
Research Institutes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drug Discovery Enzymes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drug Discovery Enzymes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Drug Discovery Enzymes market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drug Discovery Enzymes in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Company, Research Institutes and Others,, are propelling Drug Discovery Enzymes market. Active Kinases, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ubiquitin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Discovery Enzymes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Discovery Enzymes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Discovery Enzymes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Discovery Enzymes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Discovery Enzymes covered in this report include Sigma-Aldrich Co. LLC., Kaneka Corporation, Actelion Pharmaceuticals Ltd, Genesis Biotechnology Group, Suven Life Sciences Limited, Enzo Life Sciences and Merck KGaA, etc.
The global Drug Discovery Enzymes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sigma-Aldrich Co. LLC.
Kaneka Corporation
Actelion Pharmaceuticals Ltd
Genesis Biotechnology Group
Suven Life Sciences Limited
Enzo Life Sciences
Merck KGaA
Global Drug Discovery Enzymes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Discovery Enzymes market, Segment by Type:
Active Kinases
Ubiquitin
Methyltransferases
Deacetylases (hdacs)
Phosphodiesterases (pdes)
Others
Global Drug Discovery Enzymes market, by Application
Pharmaceutical and Biotechnology Company
Research Institutes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drug Discovery Enzymes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drug Discovery Enzymes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Drug Discovery Enzymes Market Overview
1.1 Drug Discovery Enzymes Product Overview
1.2 Drug Discovery Enzymes Market Segment by Type
1.2.1 Active Kinases
1.2.2 Ubiquitin
1.2.3 Methyltransferases
1.2.4 Deacetylases (hdacs)
1.2.5 Phosphodiesterases (pdes)
1.2.6 Others
1.3 Global Drug Discovery Enzymes Market Size by Type
1.3.1 Global Drug Discovery Enzymes Market Size Overview by Type (2018-2029)
1.3.2 Global Drug Discovery Enzymes Historic Market Size Review by Type (2018-2023)
1.3.3 Global Drug Discovery Enzymes Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drug Discovery Enzymes Sales Breakdown by Type (2018-2023)
1.4.2 Europe Drug Discovery Enzymes Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Drug Discovery Enzymes Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Drug Discovery Enzymes Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Drug Discovery Enzymes Sales Breakdown by Type (2018-2023)
2 Global Drug Discovery Enzymes Market Competition by Company
2.1 Global Top Players by Drug Discovery Enzymes Sales (2018-2023)
2.2 Global Top Players by Drug Discovery Enzymes Revenue (2018-2023)
2.3 Global Top Players by Drug Discovery Enzymes Price (2018-2023)
2.4 Global Top Manufacturers Drug Discovery Enzymes Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drug Discovery Enzymes Market Competitive Situation and Trends
2.5.1 Drug Discovery Enzymes Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Drug Discovery Enzymes Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Discovery Enzymes as of 2022)
2.7 Date of Key Manufacturers Enter into Drug Discovery Enzymes Market
2.8 Key Manufacturers Drug Discovery Enzymes Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drug Discovery Enzymes Status and Outlook by Region
3.1 Global Drug Discovery Enzymes Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Drug Discovery Enzymes Historic Market Size by Region
3.2.1 Global Drug Discovery Enzymes Sales in Volume by Region (2018-2023)
3.2.2 Global Drug Discovery Enzymes Sales in Value by Region (2018-2023)
3.2.3 Global Drug Discovery Enzymes Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Drug Discovery Enzymes Forecasted Market Size by Region
3.3.1 Global Drug Discovery Enzymes Sales in Volume by Region (2024-2029)
3.3.2 Global Drug Discovery Enzymes Sales in Value by Region (2024-2029)
3.3.3 Global Drug Discovery Enzymes Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Drug Discovery Enzymes by Application
4.1 Drug Discovery Enzymes Market Segment by Application
4.1.1 Pharmaceutical and Biotechnology Company
4.1.2 Research Institutes
4.1.3 Others
4.2 Global Drug Discovery Enzymes Market Size by Application
4.2.1 Global Drug Discovery Enzymes Market Size Overview by Application (2018-2029)
4.2.2 Global Drug Discovery Enzymes Historic Market Size Review by Application (2018-2023)
4.2.3 Global Drug Discovery Enzymes Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drug Discovery Enzymes Sales Breakdown by Application (2018-2023)
4.3.2 Europe Drug Discovery Enzymes Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Drug Discovery Enzymes Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Drug Discovery Enzymes Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Drug Discovery Enzymes Sales Breakdown by Application (2018-2023)
5 North America Drug Discovery Enzymes by Country
5.1 North America Drug Discovery Enzymes Historic Market Size by Country
5.1.1 North America Drug Discovery Enzymes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Drug Discovery Enzymes Sales in Volume by Country (2018-2023)
5.1.3 North America Drug Discovery Enzymes Sales in Value by Country (2018-2023)
5.2 North America Drug Discovery Enzymes Forecasted Market Size by Country
5.2.1 North America Drug Discovery Enzymes Sales in Volume by Country (2024-2029)
5.2.2 North America Drug Discovery Enzymes Sales in Value by Country (2024-2029)
6 Europe Drug Discovery Enzymes by Country
6.1 Europe Drug Discovery Enzymes Historic Market Size by Country
6.1.1 Europe Drug Discovery Enzymes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Drug Discovery Enzymes Sales in Volume by Country (2018-2023)
6.1.3 Europe Drug Discovery Enzymes Sales in Value by Country (2018-2023)
6.2 Europe Drug Discovery Enzymes Forecasted Market Size by Country
6.2.1 Europe Drug Discovery Enzymes Sales in Volume by Country (2024-2029)
6.2.2 Europe Drug Discovery Enzymes Sales in Value by Country (2024-2029)
7 Asia-Pacific Drug Discovery Enzymes by Region
7.1 Asia-Pacific Drug Discovery Enzymes Historic Market Size by Region
7.1.1 Asia-Pacific Drug Discovery Enzymes Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Drug Discovery Enzymes Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Drug Discovery Enzymes Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Drug Discovery Enzymes Forecasted Market Size by Region
7.2.1 Asia-Pacific Drug Discovery Enzymes Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Drug Discovery Enzymes Sales in Value by Region (2024-2029)
8 Latin America Drug Discovery Enzymes by Country
8.1 Latin America Drug Discovery Enzymes Historic Market Size by Country
8.1.1 Latin America Drug Discovery Enzymes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Drug Discovery Enzymes Sales in Volume by Country (2018-2023)
8.1.3 Latin America Drug Discovery Enzymes Sales in Value by Country (2018-2023)
8.2 Latin America Drug Discovery Enzymes Forecasted Market Size by Country
8.2.1 Latin America Drug Discovery Enzymes Sales in Volume by Country (2024-2029)
8.2.2 Latin America Drug Discovery Enzymes Sales in Value by Country (2024-2029)
9 Middle East and Africa Drug Discovery Enzymes by Country
9.1 Middle East and Africa Drug Discovery Enzymes Historic Market Size by Country
9.1.1 Middle East and Africa Drug Discovery Enzymes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Drug Discovery Enzymes Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Drug Discovery Enzymes Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Drug Discovery Enzymes Forecasted Market Size by Country
9.2.1 Middle East and Africa Drug Discovery Enzymes Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Drug Discovery Enzymes Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sigma-Aldrich Co. LLC.
10.1.1 Sigma-Aldrich Co. LLC. Company Information
10.1.2 Sigma-Aldrich Co. LLC. Introduction and Business Overview
10.1.3 Sigma-Aldrich Co. LLC. Drug Discovery Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sigma-Aldrich Co. LLC. Drug Discovery Enzymes Products Offered
10.1.5 Sigma-Aldrich Co. LLC. Recent Development
10.2 Kaneka Corporation
10.2.1 Kaneka Corporation Company Information
10.2.2 Kaneka Corporation Introduction and Business Overview
10.2.3 Kaneka Corporation Drug Discovery Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Kaneka Corporation Drug Discovery Enzymes Products Offered
10.2.5 Kaneka Corporation Recent Development
10.3 Actelion Pharmaceuticals Ltd
10.3.1 Actelion Pharmaceuticals Ltd Company Information
10.3.2 Actelion Pharmaceuticals Ltd Introduction and Business Overview
10.3.3 Actelion Pharmaceuticals Ltd Drug Discovery Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Actelion Pharmaceuticals Ltd Drug Discovery Enzymes Products Offered
10.3.5 Actelion Pharmaceuticals Ltd Recent Development
10.4 Genesis Biotechnology Group
10.4.1 Genesis Biotechnology Group Company Information
10.4.2 Genesis Biotechnology Group Introduction and Business Overview
10.4.3 Genesis Biotechnology Group Drug Discovery Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Genesis Biotechnology Group Drug Discovery Enzymes Products Offered
10.4.5 Genesis Biotechnology Group Recent Development
10.5 Suven Life Sciences Limited
10.5.1 Suven Life Sciences Limited Company Information
10.5.2 Suven Life Sciences Limited Introduction and Business Overview
10.5.3 Suven Life Sciences Limited Drug Discovery Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Suven Life Sciences Limited Drug Discovery Enzymes Products Offered
10.5.5 Suven Life Sciences Limited Recent Development
10.6 Enzo Life Sciences
10.6.1 Enzo Life Sciences Company Information
10.6.2 Enzo Life Sciences Introduction and Business Overview
10.6.3 Enzo Life Sciences Drug Discovery Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Enzo Life Sciences Drug Discovery Enzymes Products Offered
10.6.5 Enzo Life Sciences Recent Development
10.7 Merck KGaA
10.7.1 Merck KGaA Company Information
10.7.2 Merck KGaA Introduction and Business Overview
10.7.3 Merck KGaA Drug Discovery Enzymes Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck KGaA Drug Discovery Enzymes Products Offered
10.7.5 Merck KGaA Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drug Discovery Enzymes Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drug Discovery Enzymes Industrial Chain Analysis
11.4 Drug Discovery Enzymes Market Dynamics
11.4.1 Drug Discovery Enzymes Industry Trends
11.4.2 Drug Discovery Enzymes Market Drivers
11.4.3 Drug Discovery Enzymes Market Challenges
11.4.4 Drug Discovery Enzymes Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drug Discovery Enzymes Distributors
12.3 Drug Discovery Enzymes Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
